Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Inshaw

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Human Genetics : EJHG|March 24, 2020
Correction: Comparison of methods for transcriptome imputation through application to two common complex diseasesJames J Fryett, Jamie Inshaw, Andrew P Morris, et al.
European Journal of Human Genetics : EJHG|July 7, 2018
Comparison of methods for transcriptome imputation through application to two common complex diseasesJames J Fryett, Jamie Inshaw, Andrew P Morris, et al.
The Annals of Applied Statistics|January 7, 2022
A Global-Local Approach for Detecting Hotspots in Multiple-Response RegressionHélène Ruffieux, Anthony C Davison, Jörg Hager, et al.
Plos One|July 31, 2015
The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UKJamie Inshaw, Clifford Leen, Martin Fisher, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2016
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV InfectionJohn Thornhill, Jamie Inshaw, Pontiano Kaleebu, et al.
Health Technology Assessment (Winchester, England)|July 6, 2016
BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trialKarina Butler, Jamie Inshaw, Deborah Ford, et al.
Journal of the International AIDS Society|November 14, 2014
Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infectionJohn Thornhill, Jamie Inshaw, Soonita Oomeer, et al.
Rheumatology and Therapy|April 17, 2023
Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)Alan Kivitz, Wesley DeHaan, Rehan Azeem, et al.
AIDS (London, England)|October 17, 2018
Virological remission after antiretroviral therapy interruption in female African HIV seroconvertersMorgane Gossez, Genevieve Elizabeth Martin, Matthew Pace, et al.
Elife|July 15, 2024
Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trialJoanna C Porter, Jamie Inshaw, Vincente Joel Solis, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Human Genetics : EJHG|March 24, 2020
Correction: Comparison of methods for transcriptome imputation through application to two common complex diseasesJames J Fryett, Jamie Inshaw, Andrew P Morris, et al.
European Journal of Human Genetics : EJHG|July 7, 2018
Comparison of methods for transcriptome imputation through application to two common complex diseasesJames J Fryett, Jamie Inshaw, Andrew P Morris, et al.
The Annals of Applied Statistics|January 7, 2022
A Global-Local Approach for Detecting Hotspots in Multiple-Response RegressionHélène Ruffieux, Anthony C Davison, Jörg Hager, et al.
Plos One|July 31, 2015
The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UKJamie Inshaw, Clifford Leen, Martin Fisher, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2016
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV InfectionJohn Thornhill, Jamie Inshaw, Pontiano Kaleebu, et al.
Health Technology Assessment (Winchester, England)|July 6, 2016
BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trialKarina Butler, Jamie Inshaw, Deborah Ford, et al.
Journal of the International AIDS Society|November 14, 2014
Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infectionJohn Thornhill, Jamie Inshaw, Soonita Oomeer, et al.
Rheumatology and Therapy|April 17, 2023
Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)Alan Kivitz, Wesley DeHaan, Rehan Azeem, et al.
AIDS (London, England)|October 17, 2018
Virological remission after antiretroviral therapy interruption in female African HIV seroconvertersMorgane Gossez, Genevieve Elizabeth Martin, Matthew Pace, et al.
Elife|July 15, 2024
Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trialJoanna C Porter, Jamie Inshaw, Vincente Joel Solis, et al.
Pageof 2